Cargando…
Bile acid-mediated signaling in cholestatic liver diseases
Chronic cholestatic liver diseases, such as primary biliary cholangitis (PBC) and primary sclerosing cholangitis (PSC), are associated with bile stasis and gradually progress to fibrosis, cirrhosis, and liver failure, which requires liver transplantation. Although ursodeoxycholic acid is effective i...
Autores principales: | Zeng, Jing, Fan, Jiangao, Zhou, Huiping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10149012/ https://www.ncbi.nlm.nih.gov/pubmed/37120573 http://dx.doi.org/10.1186/s13578-023-01035-1 |
Ejemplares similares
-
Crosstalk between Gut Microbiota and Bile Acids in Cholestatic Liver Disease
por: Shi, Qingmiao, et al.
Publicado: (2023) -
Bile Acid Receptors and the Gut–Liver Axis in Nonalcoholic Fatty Liver Disease
por: Xue, Rui, et al.
Publicado: (2021) -
The role of bile acids in cholestatic liver injury
por: Cai, Shi-Ying, et al.
Publicado: (2021) -
Bile acids decrease intracellular bilirubin levels in the cholestatic liver: implications for bile acid-mediated oxidative stress
por: Muchova, Lucie, et al.
Publicado: (2011) -
Variation in Bile Microbiome by the Etiology of Cholestatic Liver Disease
por: Tyc, Olaf, et al.
Publicado: (2020)